Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomized, Open-Label, Non-Inferiority Study From Guangdong, China
洛匹那韦/利托那韦联合拉米夫定对 HIV-1 感染初治患者 (ALTERLL) 的抗逆转录病毒长期疗效和耐药性:中国广东一项随机、开放标签、非劣效性研究的 144 周结果
期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2020.569766
Peng-Le Guo, Hao-Lan He, Xie-Jie Chen, Jin-Feng Chen, Xiao-Ting Chen, Yun Lan, Jian Wang, Pei-Shan Du, Huo-Lin Zhong, Hong Li, Cong Liu, Li-Ya Li, Feng-Yu Hu, Xiao-Ping Tang, Wei-Ping Cai, Ling-Hua Li